Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

News / Press Releases

: Press Releases

Press Releases

Tonix Pharmaceuticals to Present at BIO CEO & Investor Conference

February 4, 2019 • 8:00 AM EST

Tonix Pharmaceuticals to Present at Upcoming Investor Conferences and Participate in Featured Panel Discussion

January 2, 2019 • 7:00 AM EST

« Previous
1
2
3
4
5
6

Show All